Summary
Orbis Research’s Medical Devices sector report, “Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2016″ provides an overview of Deep Brain Stimulators currently in pipeline stage.
Description
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/157277
Scope
– Extensive coverage of the Deep Brain Stimulators under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Purchase a copy of Deep Brain Stimulators Medical Devices Pipeline Assessment, 2016 visit @ http://www.orbisresearch.com/contact/purchase/157277
Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Deep Brain Stimulators under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Adaptive Neuromodulation GmbH
Aleva Neurotherapeutics SA
Boston Scientific Corp
Brainsway Ltd
Cerene Biomedics, Inc.
Cerevast Therapeutics Inc
Children’s Hospital Boston
Cleveland Medical Devices Inc
Clinatec
Deep Brain Innovations, LLC
Duke University
Functional Neuromodulation Inc.
Highland Instruments, Inc.
Massachusetts General Hospital
Massachusetts Institute of Technology
Mayo Clinic US
Medtronic plc
National Cheng-Kung University Hospital
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nuraleve Inc.
Soterix Medical Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical Inc
SUNY Downstate Medical Center
The University of Utah
University of California Los Angeles
University of Central Florida
University of Illinois
University of Michigan
University of Milan
University of Oxford
University of South Florida
Wedge Therapeutics